Treace Medical Concepts, Inc. Gain (Loss) on Extinguishment of Debt
Treace Medical Concepts, Inc. (TMCI) reported Gain (Loss) on Extinguishment of Debt of $2.74 million for the 3-month period ending 2025-12-31, per its DEF 14A filed 2026-04-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-04-06
- Treace Medical Concepts, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $2.74M.
- Treace Medical Concepts, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- Treace Medical Concepts, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- Treace Medical Concepts, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was $0.00.
- Treace Medical Concepts, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
- Treace Medical Concepts, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was -$4.48M.
- Treace Medical Concepts, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $0.00.
- Treace Medical Concepts, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $2.74M DEF 14A · filed 2026-04-06 | $2.74M DEF 14A · filed 2026-04-06 | -$2.74M 10-K · filed 2026-02-27 | ||||
| 2024-12-31 | $0.00 DEF 14A · filed 2026-04-06 | $0.00 DEF 14A · filed 2026-04-06 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | |||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $4.48M derived: sum of 3 quarters · filed 2025-02-27 | -$4.48M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $4.48M derived: sum of 2 quarters · filed 2023-11-09 | -$4.48M 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | $4.48M 10-Q · filed 2023-08-09 | -$4.48M 10-Q · filed 2022-08-10 | $4.48M 10-Q · filed 2023-08-09 | -$4.48M 10-Q · filed 2022-08-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | |||||
| 2020-12-31 | $639.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $0.00 10-K · filed 2023-03-08 | -$639.00K 10-K · filed 2022-03-04 | ||||
| 2020-09-30 | -$639.00K 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |